PharVision Advisers
SITC icon

PharVision Advisers’s SITE Centers SITC Stock Holding History

PharVision Advisers’s Portfolio SITC Stock Details SITC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$38.7K Sell
11,484
-5,773
-33% -$20K 1.57% 24
2026
Q2 		$68.5K Buy
+17,257
New +$89.9K 1.29% 47
2025
Q3 		– Sell
-14,021
Closed -$159K – 781
2025
Q2 		$159K Buy
+14,021
New +$168K 0.23% 225

Other funds holding SITC

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Beverly Hills Private Wealth
Beverly Hills Private Wealth Beverly Hills, California $579M AUM 18.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

PharVision Advisers's SITC Position: Q3 2026 in Review

PharVision Advisers reduced its SITE Centers (SITC) stake by 33% in Q3 2026, selling an estimated $20K and leaving 11,484 shares worth $38.7K. The position accounts for 1.57% of the portfolio, ranked #24.

PharVision Advisers first reported a position in SITC in Q2 2025 and has held it in 3 quarters since. The position peaked at $159K in Q2 2025. 127 funds tracked by Wall St. Rank hold SITC as of Q3 2026.

  • PharVision Advisers held 11,484 shares of SITE Centers worth $38.7K as of Q3 2026.
  • PharVision Advisers sold 5,773 SITE Centers shares in Q3 2026, an estimated $20K.
  • SITE Centers made up 1.57% of PharVision Advisers's portfolio in Q3 2026, its #24 holding.
  • PharVision Advisers first reported a position in SITE Centers in Q2 2025 and has held it in 3 quarters since.
  • PharVision Advisers's SITE Centers position peaked at $159K in Q2 2025.
  • 127 funds tracked by Wall St. Rank held SITE Centers as of Q3 2026.

Based on PharVision Advisers's 13F filing for Q3 2026, filed 29 Oct 2026.